0001415889-24-007243.txt : 20240307
0001415889-24-007243.hdr.sgml : 20240307
20240307214019
ACCESSION NUMBER: 0001415889-24-007243
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240229
FILED AS OF DATE: 20240307
DATE AS OF CHANGE: 20240307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Moshkevich Solomon
CENTRAL INDEX KEY: 0002010019
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37478
FILM NUMBER: 24732170
MAIL ADDRESS:
STREET 1: C/O NATERA, INC.
STREET 2: 13011 MCCALLEN PASS, BLDG A, SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78753
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Natera, Inc.
CENTRAL INDEX KEY: 0001604821
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 010894487
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 13011 MCCALLEN PASS
STREET 2: BUILDING A SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78753
BUSINESS PHONE: 650-249-9090
MAIL ADDRESS:
STREET 1: 13011 MCCALLEN PASS
STREET 2: BUILDING A SUITE 100
CITY: AUSTIN
STATE: TX
ZIP: 78753
4
1
form4-03072024_090309.xml
X0508
4
2024-02-29
0001604821
Natera, Inc.
NTRA
0002010019
Moshkevich Solomon
C/O NATERA, INC.
13011 MCCALLEN PASS BUILDING A SUITE 100
AUSTIN
TX
78753
false
true
false
false
PRESIDENT, CLINICALDIAGNOSTICS
0
Common Stock
2024-02-29
4
A
0
3206
A
200512
D
Common Stock
2024-03-05
4
S
0
18
87.3258
D
200494
D
Common Stock
2024-03-05
4
S
0
2227
88.3650
D
198267
D
On June 10, 2022, the Reporting Person was granted performance-based Restricted Stock Units (the "RSUs") covering 12,826 shares of Common Stock vesting in tranches upon the Issuer achieving certain specified financial and operating metrics. On February 29, 2024, the achievement of milestones for the vesting of RSUs covering 3,206 shares of Common Stock was certified.
Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs and in compliance with Rule 10b5-1.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $87.31 to $87.3415 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
/s/ Tami Chen, Attorney-in-Fact
2024-03-07